A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors.

Autor: Wallen, Zachary D¹ (AUTHOR) zachary.wallen@labcorp.com, Nesline, Mary K¹ (AUTHOR), Pabla, Sarabjot¹ (AUTHOR), Gao, Shuang¹ (AUTHOR), Vanroey, Erik¹ (AUTHOR), Hastings, Stephanie B¹ (AUTHOR), Ko, Heidi¹ (AUTHOR), Strickland, Kyle C^1,2 (AUTHOR), Previs, Rebecca A^1,3 (AUTHOR), Zhang, Shengle¹ (AUTHOR), Conroy, Jeffrey M¹ (AUTHOR), Jensen, Taylor J¹ (AUTHOR), George, Elizabeth⁴ (AUTHOR), Eisenberg, Marcia⁴ (AUTHOR), Caveney, Brian⁴ (AUTHOR), Sathyan, Pratheesh⁵ (AUTHOR), Ramkissoon, Shakti^1,6 (AUTHOR), Severson, Eric A¹ (AUTHOR)

Publikováno v: Briefings in Bioinformatics. Nov2024, Vol. 25 Issue 6, p1-16. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes.

Autor: Nesline, Mary K.¹ (AUTHOR) neslim1@labcorp.com, Previs, Rebecca A.^1,2 (AUTHOR) eric.severson@labcorp.com, Dy, Grace K.³ (AUTHOR) grace.dy@roswellpark.org, Deng, Lei⁴ (AUTHOR) lei.deng@roswellpark.org, Lee, Yong Hee⁵ (AUTHOR), DePietro, Paul⁶ (AUTHOR) depietp@labcorp.com, Zhang, Shengle⁶ (AUTHOR) zhangs7@labcorp.com, Meyers, Nathan⁶ (AUTHOR) meyersn@labcorp.com, Severson, Eric¹ (AUTHOR) shakti.ramkissoon@labcorp.com, Ramkissoon, Shakti^1,7 (AUTHOR), Pabla, Sarabjot⁶ (AUTHOR) pablas@labcorp.com, Conroy, Jeffrey M.⁶ (AUTHOR) conroj2@labcorp.com

Publikováno v: Cancers. Oct2023, Vol. 15 Issue 19, p4789. 16p.

OX40/OX40 ligand and its role in precision immune oncology.

Autor: Thapa, Bicky, Kato, Shumei, Nishizaki, Daisuke, Miyashita, Hirotaka, Lee, Suzanna, Nesline, Mary K., Previs, Rebecca A., Conroy, Jeffery M., DePietro, Paul, Pabla, Sarabjot, Kurzrock, Razelle

Publikováno v: Cancer & Metastasis Reviews; Sep2024, Vol. 43 Issue 3, p1001-1013, 13p

Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.

Autor: Ko, Heidi Chwan, Seager, RJ, Pabla, Sarabjot, Senosain, Maria-Fernanda, Van Roey, Erik, Gao, Shuang, Strickland, Kyle C, Previs, Rebecca Ann, Green, Michelle F, Cooper, Maureen, Nesline, Mary K, Hastings, Stephanie B, Amoah, Kobina Agyaful, Zhang, Shengle, Conroy, Jeffrey M, Jensen, Taylor J, Eisenberg, Marcia, Caveney, Brian, Severson, Eric A, Ramkissoon, Shakti

Publikováno v: Breast Cancer: Targets & Therapy; Aug2024, Vol. 16, p483-495, 13p